DarioHealth Corp.

DarioHealth Corp. is a billboard sponsor of Streetwise Reports and paid a fee for this company profile page. Please refer to the important disclosures below for additional details.

Recent Articles:

DarioHealth: Chronic Care Platform Drives Value

Streetwise Reports  (06/23/2026)

DarioHealth targets the booming digital health market with a multi-condition platform backed by 27 ADA studies. See pipeline growth, analyst targets, and key catalysts for investors.

Tags: Healthcare ServicesArtificial IntelligenceTechnologyMedical Devices

Four New ADA Studies Reveal Clinical Wins in Weight, Blood Sugar, and Healthcare Utilization

Streetwise Reports  (06/22/2026)

DarioHealth Corp. (DRIO:NASDAQ) presented four studies at the ADA Scientific Sessions reporting weight loss of up to 14.3%, fewer hospitalizations, and improved glycemic outcomes among high-risk cardiometabolic users of its digital health platform.

Tags: Healthcare ServicesArtificial IntelligenceTechnologyMedical Devices

New York Digital Health Firm Expands Reach to 116 Million Covered Lives

Streetwise Reports  (05/14/2026)

DarioHealth Corp. (DRIO:NASDAQ) reported first quarter 2026 results showing sequential revenue growth, lower operating expenses, expanded channel partnerships and a US$127 million commercial pipeline.

Tags: Healthcare Services

New York Healthcare Technology Co. Discovers Scalable Behavioral Health Breakthrough

Streetwise Reports  (04/28/2026)

DarioHealth Corp.'s (DRIO:NASDAQ) study showed measurable workplace productivity and cognitive function improvements in 1,254 users within weeks, boosting growth potential.

Tags: Life Sciences Tools & Diagnostics

DarioHealth Contracts With National Health Plan to Offer Behavioral Health Services to Millions of Members

Streetwise Reports  (10/14/2021)

DarioHealth Corp. shares traded 17% higher after the company reported it entered into an agreement with an unnamed national healthcare provider to make its behavioral health products available to millions of the plan's members.

Tags:  Healthcare ServicesTechnology

Experts Following This Company

Important Disclosures
DarioHealth Corp. is a Billboard advertiser of Streetwise Reports and pays a flat fee. Fees fund both sponsor-specific activities and general report activities. Sponsor-specific activities may include aggregating content and publishing that content on the Streetwise Reports site, creating and maintaining company landing pages, interviewing key management, posting a banner/billboard, and/or issuing press releases. The fees also cover the costs for Streetwise Reports to publish and syndicate investment opinion and comments, and also to curate or create sector-specific content. Billboard advertising monthly fees range from $3,000 to $5,000. This landing page contains a summary of the company that was prepared by that company. Some landing pages contain investing highlights and a catalyst calendar that are prepared by that company. The Expert Comments and Experts Following This Company sections of the landing page are compiled by Streetwise Reports. There may be other information about the company that is not placed on the landing page, and Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on the landing page. Readers should conduct their own research for all information publicly available concerning the company. This landing page may be considered advertising for the purposes of 18 U.S.C. 1734.